A north american registry for epilepsy and pregnancy, a unique public/private partnership of health surveillance

Epilepsia

Volumn 39, Issue 7, 1998, Pages 793-798

  Yerby, M S ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Antiepileptic drugs; Drug safety; North American Registry of Epilepsy Pregnancy; Pregnancy outcome

Indexed keywords

ANTICONVULSANT THERAPY; ARTICLE; DRUG CHOICE; DRUG SAFETY; EPILEPSY; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MEDICAL RECORD; PREGNANCY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; REGISTRATION;

ABNORMALITIES, DRUG-INDUCED; ADVERSE DRUG REACTION REPORTING SYSTEMS; ANTICONVULSANTS; DRUG INDUSTRY; DRUG THERAPY, COMBINATION; EPILEPSY; FEMALE; HUMANS; NORTH AMERICA; POPULATION SURVEILLANCE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PREVALENCE; REGISTRIES; UNITED STATES;

EID: 0031821317     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1998.tb01166.x     Document Type: Article

References (52)

1. Hauser WA, Annegers JF, Kurland LT. Prevalence of epilepsy in Rochester, Minnesota, 1940-1980. Epilepsia 1991;31:429.
2. Lindhout D, Meinardi H, Meijer WA, Nau H. Antiepileptic drugs and teratogenesis in two consecutive cohorts: Changes in prescription policy paralleled by changes in pattern of malformations. Neurology 1992;42(suppl 5):94-10.
3. Stumpf DA, Frost M. Seizures, anticonvulsants, and pregnancy. Am J Dis Child 1978;132:746-8.
4. Buraett CWF. A survey of the relation between epilepsy and pregnancy. J Obstet Gynecol 1946;53:539-56.
5. Higgins TA, Commerford JB. Epilepsy and Pregnancy. J Ir Med Assoc 1974;67(11):317-20.
6. Suter C, Klingman WO. Seizure states and pregnancy. Neurology 1957;7:105-18.
7. Teramo K, Hiilesmaa VK. Pregnancy and fetal complications in epileptic pregnancies: review of the literature. In: Janz D, Bossi L, Dam M, et al., eds. Epilepsy, pregnancy, and the child. New York: Raven Press, 1982:53-9.
8. Teramo K, Hiilesmaa VK, Bardy A, et al. Fetal heart rate during a maternal grand mal epileptic seizure. J Perinat Med 1979;7:3-5.
9. Yerby MS, Koepsell T, Daling J. Pregnancy complications and outcomes in a cohort of women with epilepsy. Epilepsia 1985;26: 631-5.
10. Yerby MS, Collins SD. Pregnancy: mother and child. In: Engel J, Pedley TA, eds. Epilepsy: a comprehensive textbook. Philadelphia, PA: Lippincott-Raven Publishers, 1997:2027-38.
11. Sabin M, Oxorn H. Epilepsy and pregnancy. Obstet Gynecol 1956; 7:175-99.
12. Janz D, Fuchs V. Are antiepileptic drugs harmful when given during pregnancy? German Med Monthly 1964;9:20-2.
13. German J, Kowal A, Ellers KH. Trimethadione and human teratogenesis. Teratology 1970;3:349-62.
14. Elshove J, Van Eck JHM. Aangeboren misvorminge, met name gespleten lipmet zonder gespleten verhemelte bij kinderen van moeders met epilepsie. Ned Tijdschr Geneeskd 1971;115:1371-5.
15. Speidel BD, Meadow SR. Maternal epilepsy and abnormalities of the fetus and the newborn. Lancet 1972;2:839-43.
16. South J. Teratogenic effects of anticonvulsants. Lancet 1972;2: 1154.
17. Spellacy WN. Maternal epilepsy and abnormalities of the fetus and newborn. Lancet 1972;00:00-00.
18. Bjerkdal T, Bahna SL. The course and outcome of pregnancy in women with epilepsy. Acta Obstet Gynecol Scand 1973;52:245-8.
19. Fedrick J. Epilepsy and pregnancy: a report from the Oxford record linkage study. Br Med J 1973;2:442-8.
20. Koppe JG, Bosmon W, Oppers VM, et al. Epilepsie en aangeborn afwijkingen. Ned Tijdschr Genesskd 1973;117:220-4.
21. Kuenssberg EV, Knox JDE. Teratogenic effect of anticonvulsants. Lancet 1973;1:198.
22. Lowe CR. Congenital malformations among infants born to epileptic women. Lancet 1973;1:9-10.
23. Meyer JG. The teratological effects of anticonvulsants and the effects of pregnancy and birth. Eur Neurol 1973;10:179-80.
24. Millar JHD, Nevin NC. Congenital malformations and anticonvulsant drugs, lancet 1973;2:328.
25. Monson RR, Rosenberg L, Hartz SC. Diphenylhydantoin and selected congenital malformations. N Engl J Med 1973;289:1049-52.
26. Niswander JD, Wertelecki W. Congenital malformations among offspring of epileptic women. Lancet 1973;1:1062.
27. Biale Y, Lewenthal H, Aderet NB. Congenital malformations due to anticonvulsant drugs. Obstet Gynecol 1975;45:439-42.
28. Knight AH, Rhind EG. Epilepsy and pregnancy: a study of 153 pregnancies in 59 patients. Epilepsia 1975 ;16:99-110.
29. Starreveld-Zimmerman AAE, Van Der Kolk WJ, Meinardi H. Are anticonvulsants teratogenic? Lancet 1973;2:48-9.
30. Visser GH, Hisjes HJ, Elshove J. Anticonvulsants and fetal malformations. Lancet 1976;1:970.
31. Weber M, Schweitzer M, Mur JM, Andre M, Tridon P, Vett P. Epilepsie medicaments antiepileptiques et grossesse. Arch Fr Pediatr 1977;34:374-83.
32. Annegers JF, Hauser WA, Elveback LR, Anderson VE, Kurland LT. Congenital malformations and seizure disorders in the offspring of parents with epilepsy. Int J Epidemiol 1978;7:241-7.
33. Seino M, Miyakoshi M. Teratogenic risks of antiepileptic drugs in respect to the type of epilepsy. Folia Psychiat Neurol Jpn 1979; 33:379-85.
34. Dieterich E, Steveling A, Lukas A, Seyfeddinipur N, Spranger J. Congenital anomalies in children of epileptic mothers and fathers. Neuropediatrics 1980;11:274-83.
35. Majewski F, Raft W, Fischer P, Huenges R, Petruch F. Zur Tertogenitat von Anticonvulsiva. Dtsch Med Wochensch 1980;105: 719-23.
36. Nakane Y, Oltuma T, Takahashi R. et al. Multi-institutional study on the teratogenicity and fetal toxicity of anticonvulsants: a report of a collaborative study group in Japan. Epilepsia 1980;21:663-80.
37. Hiilesmaa VK, Teramo K, Granstrom ML, Bardy AH. Fetal head growth retardation associated with maternal antiepileptic drugs. Lancet 1981;2:165-7.
38. Lindhout D, Hoeppener RJEA, Meinardi H. Teratogenicity of antiepileptic drug combinations with special emphasis on epoxidation (of carbamazepine). Epilepsia 1984;25:77-83.
39. Stanley FJ, Priscott PK, Johnston R, Brooks B, Bower S. Congenital malformations in infants of mothers with diabetes and epilepsy in Western Australia, 1980-82. Med J Aust 1985;143:440-2.
40. Beaussart-Defaye J, Bastin N, Demarcq C. Epilepsies and reproduction. Lille, France: Grine, 1986.
41. Kallen B. A register study of maternal epilepsy and delivery outcome with special reference to drug use. Acta Neurol Scand 1986; 73:253-9.
42. Robert E, Lofkvist E, Mauguiere F, Robert JM. Evaluation of drug therapy and teratogenic risk in a Rhône-Alps district population of pregnant epileptic women. Eur Neurol 1986;25:436-43.
43. Rating D, Jager-Roman E, Koch S, et al. Major malformations and minor anomalies in infants exposed to different anticonvulsants during pregnancy. Adv Epileptol 1987;16:561-5.
44. Gaily E, Kantola-Sorsa E, Granstrom ML. Specific cognitive dysfunction in children with epileptic mothers. Dev Child Neurol 1990;32:403-14.
45. Dravet C, Julian C, Legras C, et al. Epilepsy, antiepileptic drugs, and malformations in children of women with epilepsy: a French prospective cohort study. Neurology 1992;42(suppl 5):S75-82.
46. Kaneko S, Otani K, Fukushima Y, et al. Malformation in infants of mothers with epilepsy receiving antiepiletics drugs. Neurology 1992;42(suppl 5):S68-74.
47. Koch S, Losche G, Jager-Roman E, et al. Major and minor birth malformations and antiepileptic drugs. Neurology 1992;42(suppl 5):S83-88.
48. Tanganelli P, Regesta G. Epilepsy, pregnancy, and major birth anomalies: an Italian prospective, controlled study. Neurology 1992;42(suppl 5):S89-93.
49. Annegers JF, Elveback LR, Hauser WA, et al. Do anticonvulsants have a teratogenic effect? Arch Neurol 1974;31:364-73.
50. Nakane Y. Congenital malformations among infants of epileptic mothers treated during pregnancy. Fol Psychiatr Neurol Jpn 1979; 33:363-9.
51. Dansky LV, Andermann E, Sherwin AL, Andermann F, Kinch RA. Maternal epilepsy and congenital malformations: a prospective study with monitoring of plasma anticonvulsant levels during pregnancy. Neurology 1980;3:15.
52. Anonymous. [Editorial]. Lancet.